URINARY HEXOSAMINIDASE IN PATIENTS WITH LUNG-CARCINOMA

被引：0
|
作者：
BRATTAIN, MG
KIMBALL, PM
DURANT, JR
PRETLOW, TG
SMITH, D
CARPENTER, J
MARKS, M
机构：
[1] UNIV ALABAMA, MED CTR, DEPT BIOCHEM, BIRMINGHAM, AL 35294 USA
[2] UNIV ALABAMA, MED CTR, DEPT PATHOL, BIRMINGHAM, AL 35294 USA
[3] UNIV ALABAMA, MED CTR, DEPT MED, BIRMINGHAM, AL 35294 USA
[4] UNIV ALABAMA, MED CTR, CTR COMPREHENS CANC, BIRMINGHAM, AL 35294 USA
来源：
CANCER | 1979年 / 44卷 / 06期
关键词：
D O I：
10.1002/1097-0142(197912)44:6<2267::AID-CNCR2820440640>3.0.CO;2-M
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The specific activity of urinary hexosaminidase was determined in 58 patients with various histological types of lung carcinoma. Compared to an apparently healthy control population, 32/35 patients with widely disseminated disease showed elevated values and 18/23 patients with disease confined to the chest had normal hexosaminidase values. Detailed studies of 18 patients indicated that declining hexosaminidase values were associated with effective therapy; rising values generally accompanied progressive disease.
引用
收藏
页码：2267 / 2272
页数：6
相关论文
共 50 条
  • [1] ANTIPERINUCLEAR ACTIVITY IN LUNG-CARCINOMA PATIENTS
    YOUINOU, P
    ZABBE, C
    EVEILLAUD, C
    DEWITTE, JD
    KERBOURCH, JF
    FEREC, C
    CLAVIER, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1984, 18 (02) : 80 - 81
  • [2] SCINTIGRAPHIC EVALUATION OF PATIENTS WITH LUNG-CARCINOMA
    ALDERSON, PO
    CHEST, 1986, 89 (04) : S245 - S248
  • [3] THE INFLUENCE OF PLASMAPHERESIS ON HEMOSTASIS IN PATIENTS WITH LUNG-CARCINOMA
    TARABYKIN, AA
    KLYACHKIN, BM
    BASARGIN, ST
    TERAPEVTICHESKII ARKHIV, 1990, 62 (09) : 108 - 111
  • [4] LYMPHOCYTE NUCLEOLAR COEFFICIENT IN LUNG-CARCINOMA PATIENTS
    BAKARDJIEV, GT
    DASKALOV, AN
    DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE, 1985, 38 (10): : 1419 - 1422
  • [5] SURGERY FOR LUNG-CARCINOMA IN PATIENTS WITH PREOPERATIVE IRRADIATION
    DOBROVOLSKY, SR
    GRIGORYEVA, SP
    IVANOV, AN
    FISHKOVA, ZP
    KHIRURGIYA, 1994, (06): : 13 - 17
  • [6] THYMUS FUNCTION IN PATIENTS WITH RESECTABLE LUNG-CARCINOMA
    ISRAEL, L
    HAJJI, F
    RIGAUT, JP
    AMOUROUX, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1984, 18 (01) : 24 - 28
  • [7] IMMUNOSCINTIGRAPHY OF LUNG-CARCINOMA - EXPERIENCE IN 45 PATIENTS
    RIVA, P
    PAGANELLI, G
    RICIPUTI, G
    PASINI, G
    BENINI, S
    AGOSTINI, M
    MOSCATELLI, G
    CACCIAGUERRA, G
    TISON, V
    MORIGI, P
    STANCANELLI, V
    BRITISH JOURNAL OF CANCER, 1986, 54 (03) : 538 - 538
  • [8] LUNG-CARCINOMA IN 1,336 PATIENTS
    SRIDHAR, KS
    RAUB, W
    DUNCAN, RC
    HILSENBECK, S
    RICHMAN, SP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (06): : 496 - 508
  • [9] GLYCOSAMINOGLYCANS IN LUNG-CARCINOMA
    KAWAI, T
    SUZUKI, M
    KAGEYAMA, K
    HUMAN PATHOLOGY, 1988, 19 (11) : 1288 - 1292
  • [10] THE PATHOMORPHOLOGY OF LUNG-CARCINOMA
    FASSKE, E
    PATHOLOGE, 1981, 2 (02): : 123 - 123
12345